1290636-57-5

Basic information

• Product Name: 2-(3-chlorophenyl)-3-methyl-6-(quinuclidin-3-yloxy)quinazolin-4(3H)-one
• Synonyms: 2-(3-chlorophenyl)-3-methyl-6-(quinuclidin-3-yloxy)quinazolin-4(3H)-one
• CAS NO: 1290636-57-5
• Molecular Weight: 395.889
• Mol File: 1290636-57-5.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 2-(3-chlorophenyl)-3-methyl-6-(quinuclidin-3-yloxy)quinazolin-4(3H)-one(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(3-chlorophenyl)-3-methyl-6-(quinuclidin-3-yloxy)quinazolin-4(3H)-one(1290636-57-5)
• EPA Substance Registry System: 2-(3-chlorophenyl)-3-methyl-6-(quinuclidin-3-yloxy)quinazolin-4(3H)-one(1290636-57-5)

Safety Data

• Hazardous Substances Data: 1290636-57-5(Hazardous Substances Data)

Upstream product

• 195986-91-5 6-hydroxy-1,2-dihydro-4H-3,1-benzoxazin-2,4-dione 
• 1290634-54-6 2-(3-chlorophenyl)-6-hydroxy-3-methylquinazolin-4(3H)-one 
• 1619-34-7 3-quinuclidinol 
• 1018983-66-8 2-amino-5-hydroxy-N-methylbenzamide 

Relevant articles and documents

CONDENSED AZINE - DERIVATIVES FOR THE TREATMENT OF DISEASES RELATED TO THE ACETYLCHOLINE RECEPTOR

The present invention relates to a heterocyclic derivative of formula (I) wherein the variables are as defined in the specification or to a pharmaceutically acceptable salt or solvate thereof. The present invention further relates to pharmaceutical compositions comprising said heterocyclic derivatives and to their use in therapy, for instance in the treatment or prevention of disorders mediated by nicotinic acetylcholine receptors, such as schizophrenia and Alzheimer's disease.